实丰文化发展股份有限公司董事会 2026年2月12日 实丰文化发展股份有限公司（以下简称"公司"、"实丰文化"或"上市公司"）于近日收到公司控股股东蔡 俊权先生之一致行动人蔡俊淞先生发来的《告知函》，蔡俊淞先生在2026年2月10日通过大宗交易方式 减持公司股份840,000股，占公司总股本的0.50%。根据有关法律法规和规范性文件的要求，现将具体情 况公告如下： ■ 特此公告。 登录新浪财经APP 搜索【信披】查看更多考评等级 股东蔡俊淞先生保证向本公司提供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及公司全体董事会成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重 大遗漏。 一、股东股份解除质押基本情况 ■ 公司股东上述质押行为不存在平仓风险或被强制过户风险，由此产生的质押风险在可控范围之内。公司 将持续关注其质押变动情况及风险，并及时履行信息披露义务，敬请投资者注意风险。 二、备查文件 1．股份解除质押登记证明； 2．中国证券登记结算有限责任公司股份冻结明细； 3．中国证券登记结算有限责任公司持股5%以上股东每日持股变化明细。 近日，华林证券股份有限公司（以下简称"公司"）接到控股股东深圳市立业集团有限公司（以下简 称"立业集团"）通知，获悉其所持有本公司的部分股份已解除质押，具体事项如下： 1.本次解除质押基本情况 ■ 2．股东股份累计质押基本情况 截至公告披露日，控股股东立业集团所持质押股份情况如下： 二〇二六年二月十二日 华林证券股份有限公司董事会 ...

Core Viewpoint - Harbin Sanlian Pharmaceutical Co., Ltd. has approved a capital reduction and corresponding amendments to its articles of association, following the repurchase and cancellation of 3,000 restricted stocks from its 2022 incentive plan [1][2]. Group 1: Company Actions - The company held its fourth board meeting on September 17, 2025, and a temporary shareholders' meeting on November 24, 2025, to discuss the capital reduction [1]. - The company has completed the registration change for its capital reduction and received a new business license from the Harbin New Area Management Committee [1]. Group 2: Company Information - The registered capital of Harbin Sanlian Pharmaceutical is now RMB 316,354,550 [1]. - The company was established on June 21, 1996, and operates in various sectors including drug production, wholesale, retail, and import/export, as well as cosmetics and food production [1][2]. - The company is classified as a joint-stock company and is publicly listed [1].

Core Viewpoint - The company, Shaanxi Zhongtian Rocket Technology Co., Ltd., has triggered the conditional redemption of its convertible bonds, "Tianjian Convertible Bonds," due to the stock price meeting specific criteria, leading to an early redemption scheduled for March 6, 2026 [4][11]. Group 1: Redemption Details - The redemption conditions for the convertible bonds are met as the company's stock price has been above 130% of the conversion price for at least 15 trading days within a 30-day period [4][11]. - The redemption price is set at 100.81 yuan per bond, which includes accrued interest at an annual rate of 1.50% [2][12]. - The redemption process includes a series of key dates: the last trading day is March 3, 2026, and the redemption registration date is March 5, 2026 [3][15]. Group 2: Bond Issuance and Trading - The company issued 4,950,000 convertible bonds on August 22, 2022, with a total value of 49.5 million yuan, and these bonds began trading on September 19, 2022 [5][4]. - The initial conversion price was set at 53.11 yuan per share, which has been adjusted multiple times due to dividend distributions [6][7][8]. Group 3: Conversion and Trading Procedures - The conversion period for the bonds lasts from six months after issuance until the maturity date [6][10]. - Holders of the convertible bonds must apply for conversion through the securities company that holds their bonds, with a minimum conversion unit of one bond [16].

Group 1 - The company received a written resignation letter from director Hu Min due to job relocation [2] - Hu Min's resignation will not result in the board having fewer members than the legal minimum, ensuring the normal operation of the board [2] - The resignation will take effect upon delivery to the board, and the company will proceed with the election of a new director according to legal procedures [2]

Fundraising Overview - The company has successfully raised a total of RMB 706,999,968.84 through the issuance of 21,647,274 shares at a price of RMB 32.66 per share, with a net amount of RMB 692,070,721.95 after deducting issuance costs [1][2] - The funds have been deposited into a dedicated fundraising supervision account as of February 6, 2026, and have been verified by Tianjian Accounting Firm [1] Fund Management and Agreements - The company has established a special account for fundraising management, authorized by the third extraordinary shareholders' meeting in 2025, and has signed tripartite and quadripartite supervision agreements with relevant banks and the underwriter [2][4][5] - The tripartite agreement involves the company, China Construction Bank, Agricultural Bank of China, and the underwriter, while the quadripartite agreement includes the company, its subsidiary, and two additional banks [4][5] Fund Allocation and Usage - As of February 10, 2026, the balance in the special account at Jiaxing Bank is RMB 416,773,969.40, which includes RMB 196,273,969.40 for working capital and RMB 220,500,000.00 for the electronic-grade functional materials expansion project [3] - The company plans to use the funds for capital increase in its subsidiary, which will be subject to board approval before the transfer of funds [3] Regulatory Compliance - The agreements stipulate that the special account is exclusively for fundraising storage and usage, and both parties must comply with relevant laws and regulations [6] - The underwriter is responsible for supervising the use of funds and must conduct regular checks and audits [6][8]

Fundraising Overview - The company was approved to publicly issue 33,258,134 shares at a price of 21.96 RMB per share, raising approximately 730.35 million RMB, with a net amount of about 656.86 million RMB after deducting issuance costs [2] Change in Fund Usage - The company decided to change the use of part of the raised funds from a "100,000 tons/year multi-category plastic bottle high-quality recycling project" to a "5 million m² new decorative building materials project," reallocating 142.64 million RMB, which is 21.72% of the net amount raised [3][4] New Fund Management Agreements - The company established new special accounts for the raised funds and signed tripartite supervision agreements with its underwriter and banks to ensure compliance with regulations and protect investor interests [4][5][13] Special Account Details - As of February 9, 2026, the special account for the new project had a balance of approximately 22.64 million RMB, and the funds are strictly designated for the specified projects [5][13] Monitoring and Compliance - The underwriter is responsible for supervising the use of the raised funds, with provisions for regular audits and reporting to ensure adherence to the agreements [6][12][16] Reporting Obligations - The bank is required to provide monthly account statements to the company and the underwriter, ensuring transparency in fund management [11][16]

Group 1 - The company achieved an operating income of 483,815.26 million RMB in 2025, representing a year-on-year growth of 23.04% [2] - The net profit attributable to the parent company reached 93,503.03 million RMB, with a year-on-year increase of 45.89% [2] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 88,023.43 million RMB, showing a growth of 62.77% year-on-year [2] Group 2 - Total assets at the end of 2025 amounted to 725,222.49 million RMB, an increase of 14.98% compared to the beginning of the reporting period [2] - The equity attributable to the parent company was 386,925.38 million RMB, reflecting an 8.75% growth from the beginning of the reporting period [2] Group 3 - The company's performance was driven by embracing AI technologies, particularly in smart vehicle diagnostic terminals and smart energy hubs, which provided intelligent services to global customers [3] - In the smart charging sector, the company enhanced its end-to-end system capabilities, solidifying its position in various global industries [3][4] Group 4 - The significant growth in operating profit, total profit, and net profit attributable to the parent company was primarily due to improved profitability and operational efficiency [5] - The company's share capital increased significantly due to a rights issue in May 2025, where every 10 shares were converted into 4.9 additional shares [5] Group 5 - The company corrected its earnings forecast for 2025, with the net profit attributable to the parent company exceeding the upper limit of the previous forecast by 503.03 million RMB [7][8] - This adjustment was influenced by a court ruling that invalidated a patent dispute, allowing the company to reverse previously accrued liabilities of 24.79 million RMB [8]

登录新浪财经APP 搜索【信披】查看更多考评等级 公司简称：博瑞传播 证券代码：600880 编号：2026-004号 成都博瑞传播股份有限公司 公司将持续关注上述事项的进展情况，并按照相关法律法规的规定，及时履行相关信息披露义务。敬请 广大投资者理性投资，注意投资风险。 特此公告。 成都博瑞传播股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、本次无偿划转的基本情况 成都博瑞传播股份有限公司（以下简称"公司"）控股股东成都传媒集团拟将直接所持的公司股份 133,612,937股（占公司总股本的12.22%）及成都新闻实业有限责任公司（下称"新闻实业"）100%股权 无偿划转至其全资子公司成都传媒产业集团有限公司。本次无偿划转完成后，成都传媒产业集团将直接 取得公司12.22%股份，并通过取得新闻实业100%股权间接拥有公司23.37%的股份权益，合计持有公司 35.59%股份。公司实际控制人仍为成都市国有资产监督管理委员会。公司已于2025年10月30日、2026 年1月16日、2026年1月17日在上海证券 ...

证券代码：002130 证券简称：沃尔核材 公告编号：2026－008 公司已确定本次H股发行的最终价格为每股20.09港元（不包括1%经纪佣金、0.0027%香港证券及期货事 务监察委员会交易征费、0.00565%香港联交所交易费及0.00015%香港会计及财务汇报局交易征费）。 公司本次发行的H股将于2026年2月13日在香港联交所主板挂牌并开始上市交易。 特此公告。 深圳市沃尔核材股份有限公司董事会 2026年2月12日 深圳市沃尔核材股份有限公司 关于境外上市外资股（H股）公开发行价格的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗漏。 深圳市沃尔核材股份有限公司（以下简称"公司"）正在进行申请发行境外上市外资股（H股）并在香港 联合交易所有限公司（以下简称"香港联交所"）主板上市的相关工作（以下简称"本次境外发行上 市"）。 本次拟发行的H股股份的认购对象仅限于符合相应条件的境外投资者及依据中国相关法律法规有权进行 境外证券投资管理的境内证券经营机构和合格境内机构投资者及其他符合监管规定的投资者。因此，本 公告仅为A股投资者及时了解公司本次境外发行上市的 ...